David P. Meeker, President and CEO at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 8,722 shares at $45.06 ($393K) on 2024-02-01, disclosed to the SEC on 2024-02-05.
Open-market sale of $393k RYTM by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.06 | 4,361 | $197K | 50.0% |
| 2 | $45.06 | 4,361 | $197K | 50.0% |
| Total | $45.06 avg | 8,722 | $393K | 100% |
| Filing → |
| RYTM | SELL | 2025-02-19 | $1.1M | — | Filing → |
| RYTM | SELL | 2025-02-04 | $508K | — | Filing → |
| TRVI | SELL | 2024-08-29 | $13K | — | Filing → |